1 / 1

BRCA 1 Deletion Duplication Assay

BRCA1 Deletion / Duplication Assay has been used for the detection of large genomic deletions or duplications in the human BRCA1 gene for the confirmation of potential cause and clinical diagnosis for hereditary breast and ovarian carcinoma. DDRC SRL Diagnostics is currently conducting this test for breast and ovarian cancer patients and at-risk family members.

kmathewriya
Download Presentation

BRCA 1 Deletion Duplication Assay

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Genetics BRCA 1 Deletion / Duplication assay Test Code: Test indication: Methodology: TAT: Sample type : Sample storage and Transportation : Recommendation: Sample unacceptable criteria: BRCA 1 Deletion / Duplication assay Suspected Breast and Ovarian cancer patient and at risk family members MLPA Screening technology 3 working days 5 ml EDTA Whole Blood Sample to be stored and transported in 2 to 8 degree temperature Kindly include relavent clinical histroy and indications FFPE Tissue, sample collected in other than EDTA, samples not maintained in above recommeded temperature conditions, Clotted or hemolyzed specimen. Other assays Available: Real time PCR based EGFR mutation detection (Liquid Biopsy is also performed in Plasma) BCRABL (Major), KRAS, BRAF, JAK2 (Exon 14). NGS based Cancer Hotspot assay covering almost all cancer types (Hotspots – Most frequent mutations) BRCA Plus Inherited Breast and Ovarian cancer panel Corporate Office & Referral Laboratory, DDRC SRL Towers, Panampilly Nagar, Kochi-682 036 Ph: +91 484 2318222, 2318223 email: info@ddrcsrl.com www.ddrcsrl.com 94963 98078 85906 01094

More Related